New York, NY, November 02, 2017 --(PR.com
)-- The second annual “Charit-EoE Concert for a Cure for Eosino…what???” is set for the Intercontinental New York Barclay in New York City on Friday, November 10, with doors opening at 7:30 PM. Lance and Arlene Steinberg will host this evening of music and fundraising to benefit APFED’s HOPE on the Horizon Research Fund.
The benefit concert will feature an exclusive performance by the legendary Mike DelGuidice and Big Shot, celebrating the music of Billy Joel. The evening will also include a return performance by FRANK!, the Fairfield Connecticut School of Rock Band. In addition, Lonnie Quinn of CBS 2 News will be making a special appearance.
General admission tickets can be purchased now at http://apfed.org/events/concert-for-a-cure/ for a cost of $150 per person. The event is expected to sell out. The ticket price includes three hours of cocktails, light fare, a gift bag filled with a variety of items from generous sponsors, and an incredible night of awareness, music, community, and fun.
Proceeds from the concert will benefit APFED’s HOPE on the Horizon Research Fund, which awards grants to investigators who initiate new projects relevant to eosinophilic esophagitis (EoE) and other eosinophil-associated diseases.
“We are delighted to be doing this event for the second year. Last year’s benefit concert was such an amazing, life-changing event for all involved,” said Lance and Arlene Steinberg. “We are grateful for the opportunity to bring such a special night of music to this community and to support APFED and its groundbreaking research program.”
“This is a night to honor, celebrate, and support patients and families,” added APFED Executive Director Mary Jo Strobel. “We truly value our partnership with the Steinberg family and their commitment to advancing research. This event has not only the gifts of music and community, but also creates hope through the new projects that it makes possible.”
APFED is grateful for the support of the following Double Platinum Sponsors: The Chan Family, InterContinental Hotel Group, and Flintlock Construction Services, LLC. We also thank the following Platinum Sponsors: Adare Pharmaceuticals, Inc; Barbara & Jerry Burstein; Furniture Design Knossos, Inc; The Steinberg Family; and Stonehill & Taylor Architects, PC.
About Eosinophilic Esophagitis (EoE)
Eosinophilic esophagitis (EoE) is a chronic, allergic inflammatory disease of the esophagus (the tube connecting the mouth to the stomach). It occurs when a type of white blood cell, the eosinophil, accumulates in the esophagus and persists despite acid-blocking medicine. The elevated number of eosinophils cause injury and inflammation to the esophagus. This damage may make eating difficult or uncomfortable, potentially resulting in poor growth, chronic pain, and/or difficulty swallowing.
EoE is a subset of a group of rare, chronic conditions known as eosinophil-associated diseases. When a person has elevated numbers of eosinophils in their digestive system, tissues, organs, and/or bloodstream, without a known cause, he or she may have an eosinophil-associated disease. Due to the lack of information or awareness of these diseases, patients may suffer for years trying to obtain an accurate diagnosis and appropriate treatment. Although not commonly life-threatening, these chronic diseases require lifelong treatment and can cause debilitating symptoms. There is no cure and no FDA-approved treatments.
About American Partnership for Eosinophilic Disorders (APFED)
American Partnership for Eosinophilic Disorders (APFED) is a non-profit organization dedicated to patients and their families coping with eosinophilic disorders. APFED’s mission is to passionately embrace, support, and improve the lives of patients and families affected by eosinophil-associated diseases through education and awareness, research, support, and advocacy. www.apfed.org